Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Autor: Caobelli F; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Evangelista L; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Quartuccio N; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Familiari D; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Altini C; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Castello A; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Cucinotta M; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Di Dato R; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Ferrari C; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Kokomani A; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Laghai I; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Laudicella R; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Migliari S; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Orsini F; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Pignata SA; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Popescu C; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Puta E; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Ricci M; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Seghezzi S; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Sindoni A; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Sollini M; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Sturiale L; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Svyridenka A; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Vergura V; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Alongi P; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland., Young Aimn Working Group; Federico Caobelli, Department of Nuclear Medicine, Universitätsspital Basel, CH-4032 Basel, Switzerland.

Publikováno v: World journal of radiology [World J Radiol] 2016 Oct 28; Vol. 8 (10), pp. 829-845.